Endo International PLC (ENDP)

ENDP (NASDAQ:Drugs) EQUITY
$73.83
pos +0.35
+0.48%
Today's Range: 72.84 - 76.15 | ENDP Avg Daily Volume: 1,950,600
Last Update: 09/02/15 - 1:01 PM EDT
Volume: 744,830
YTD Performance: 1.89%
Open: $74.78
Previous Close: $73.48
52 Week Range: $57.14 - $96.58
Oustanding Shares: 208,251,366
Market Cap: 16,035,355,182
6-Month Chart
TheStreet Ratings Grade for ENDP
Buy Hold Sell
A+ A A- B+ B B- C+ C C- D+ D D- E+ E E- F
TheStreet Ratings is the source for accurate ratings that you can rely upon to make sound, informed financial decisions. Click here to find out about our methodology.
Analysts Ratings
Historical Rec Current 1 Mo. Ago 2 Mo. Ago 3 Mo. Ago
Strong Buy 7 7 6 8
Moderate Buy 1 1 2 2
Hold 4 4 5 5
Moderate Sell 0 0 0 0
Strong Sell 0 0 0 0
Mean Rec. 1.71 1.71 1.88 1.77
Latest Dividend: 0.00
Latest Dividend Yield: 0.00%
Dividend Ex-Date: 12/31/69
Price Earnings Ratio: -16.92
Price Earnings Comparisons:
ENDP Sector Avg. S&P 500
-16.92 0.00 24.87
Price Performance History (%Change):
3 Mo 1 Yr 3 Y
-12.67% 15.34% 130.92%
GROWTH 12 Mo 3 Yr CAGR
Revenue 9.90 0.05 0.02
Net Income 0.00 -3.99 0.00
EPS 0.00 -4.05 0.00
Earnings for ENDP:
EBITDA 0.89B
Revenue 2.88B
Average Earnings Estimates
Qtr (09/15) Qtr (12/15) FY (12/15) FY (12/16)
Average Estimate $1.07 $1.12 $4.49 $5.30
Number of Analysts 7 5 6 7
High Estimate $1.19 $1.16 $4.55 $5.90
Low Estimate $0.96 $1.08 $4.40 $4.92
Prior Year $1.15 $1.16 $4.31 $4.49
Growth Rate (Year over Year) -6.71% -3.45% 4.10% 18.13%
Chart Benchmark Timeframe
Average Frequency Indicator Chart
Scale Symbol Comparison Bollinger Bands

bearishEndo downgraded at Morgan Stanley

Sep 1, 2015 | 6:43 AM EDT

ENDP was downgraded from Overweight to Equal-weight, Morgan Stanley said. $85 price target. Company has limited long-term growth visibility. 

bullishEndo upgraded at RBC

Jul 17, 2015 | 7:11 AM EDT

ENDP was upgraded from Outperform to Top Pick, RBC Capital said. $107 price target. Company is attractively valued and consensus numbers appear too low. 

By

Jim Cramer

 | May 18, 2015 | 3:24 PM EDT

Acquisitions cut into overabundance of companies.

By

Timothy Collins

 | May 13, 2015 | 12:30 PM EDT

Endo Pharmaceuticals could offer a short-term play.

bullishEndo estimates, target boosted at Deutsche

Apr 13, 2015 | 8:15 AM EDT

Shares of ENDP now seen reaching $96, according to Deutsche Bank. Estimates also upped, as Xiaflex should drive growth. Buy rating. 

By

Jim Cramer

 | Mar 16, 2015 | 9:30 AM EDT

Take a look at some more of its recent moves.

By

Timothy Collins

 | Mar 10, 2015 | 4:12 PM EDT

It's wise to stick with strength right now.

By

David Katz

 | Nov 25, 2014 | 2:30 PM EST

Whether it's acquiring or the acquired, Mylan is building shareholder value.

bullishEndo Health Solutions upgraded at Cantor Fitzgerald

Oct 13, 2014 | 7:54 AM EDT

ENDP upgraded to Hold, said Cantor Fitzgerald. Auxilium deal should be accretive to EPS with longer term increases in EBITDA, possibly facilitating additional M&A. 

bullishEndo upgraded at Morgan Stanley

May 2, 2014 | 8:10 AM EDT

ENDP was upgraded from Equal-weight to Overweight, Morgan Stanley said. $79 price target. Mesh settlement removes a multi-billion dollar liability. 

We are out of our dark side position in AMBA initiated a couple of months ago. At present,...
Market slowly clawing its way back a bit from yesterday's deep losses as Chinese equities ...

IN ORDER OF SIZE PUT ON
BAC $15.62.
F $13.75
HIG $45.20
JPM $61.80
C $51.10

Many are getting MORE bearish as stock prices drop. By contrast, I am growing less fearful...

REAL MONEY PRO'S BEST IDEAS

News Breaks

Powered by
Except as otherwise indicated, quotes are delayed. Quotes delayed at least 20 minutes for all exchanges. Market Data provided by Interactive Data. Company fundamental data provided by Morningstar. Earnings and ratings provided by Zacks. Mutual fund data provided by Valueline. ETF data provided by Lipper. Powered and implemented by Interactive Data Managed Solutions.

TheStreet Ratings updates stock ratings daily. However, if no rating change occurs, the data on this page does not update. The data does update after 90 days if no rating change occurs within that time period.

IDC calculates the Market Cap for the basic symbol to include common shares only. Year-to-date mutual fund returns are calculated on a monthly basis by Value Line and posted mid-month.